EVALUATION OF IMMUNOLOGICAL MARKER INTERLEUKIN-17 AMONG PATIENTS WITH DERMATOPHYTOSIS INFECTION

Emad Saud Obais; Fadhil Sami Alammar; Angham Jasim Mohammed Ali

doi:10.53555/1jxsz722

Authors

Emad Saud Obais Collage of Health and Medical Technology / Kufa, Al-Furat Al-Awsat Technical university, Iraq Author
Dr. Fadhil Sami Alammar Technical Institute/Kufa, Al-Furat Al-Awsat Technical university, Iraq Author
Dr. Angham Jasim Mohammed Ali Collage of Health and Medical Technology / Kufa, Al-Furat Al-Awsat Technical university, Iraq Author

DOI:

https://doi.org/10.53555/1jxsz722

Abstract

This study was conducted to evaluates the immunological parameter IL-17) associated with development of dermatophyte infection. The study was carried out in the period beginning of December 2022 to end of June 2023This study has been done at the Al-Hilla Teaching Hospital, Dermatology Unit, Babylon Government; ages range between 1 to ≥ 50 years in male and female. During the study a total 90 clinical specimens (Skin scraping and 5ml of blood) were obtained from all participants (45 dermatophytosis cases and 45 controls). Blood samples (serum introduced for evaluation of concentration level of IL-17 by ELISA. The ELISA was used to measure two types of cytokines (IL-17 and TNF-α), and it was observed a significant increase ( P ≤0.0001 ) of serum IL-17 in dermatophyte infected patients (35.015 ± 0.837 pg/ml) when compared with control subjects (6.481 ± 0.848 pg/ml The levels of IL-17 concentration in patients Infected with Dermatophyte Infection according to age groups appear non significant difference between age groups (P.value = 0.8780) and the highest concentration level of IL-17 appears with age group (31-40 years) and (41-50 years) and were (37.191 ± 2.806 Pg/ml) and (37.006± 0.934 Pg/ml) respectively while the lowest concentration level of IL-17 with (≤ 10 years) was (33.784 ± 4.756 Pg/ml). while in control group, appear non significant difference between age groups (P.value = 00.8991) and the highest concentration level of IL-17 appears with age group (51-60 years) and (≤ 10 years) and were (8.636 ± 2.300 Pg/ml) and (8.281 ± 1.352 Pg/ml) respectively while the lowest concentration level of IL-17 with (31-40 years) was (5.869 Pg/ml In depending on Gender, in dermatophyte infected patients group, the results have shown the high concentration level of IL-17 appear in male was (35.950 ± 0.916 Pg/ml) other than female (33.255 ± 1.643 Pg/ml) with non significant difference (P.value= 0.1266) also in control group , the results have shown the high concentration level of IL-17 appears in male was (7.383 ± 0.911 Pg/ml) and the low concentration level appears in female and was (6.544 ± 0.957 Pg/ml) , and this height also non significance (P.value= 0.5381)The concentration level of IL-17 according to duration of infection in dermatophytosis patients, appear significant difference between groups (P.value ≤0.0001) and the highest concentration level of IL-17 appears with groups (> 2 years) and was (74.083 ±9.807 Pg/ml), while the lowest concentration level of IL-17 with (≤6 month) and was (33.892 ± 2.890 Pg/ml).

References

Kovitwanichkanont, T., & Chong, A. H. (2019). Superficial fungal infections. Australian Journal of General Practice, 48(10), 706-711.

Celestrino, G. A., Verrinder Veasey, J., Benard, G., & Sousa, M. G. T. (2021). Host immune responses in dermatophytes infection. Mycoses, 64(5), 477-483.

Sardana, K., Gupta, A., & Mathachan, S. R. (2021). Immunopathogenesis of dermatophytoses and factors leading to recalcitrant infections. Indian dermatology online journal, 12(3), 389.

Vinh, D. C. (2023). Of Mycelium and Men: Inherent Human Susceptibility to Fungal Diseases. Pathogens, 12(3), 456.

Tangye, S. G., & Puel, A. (2023). The Th17/IL-17 axis and host defence against fungal infections. The Journal of Allergy and Clinical Immunology: In Practice.

Burstein, V. L., Beccacece, I., Guasconi, L., Mena, C. J., Cervi, L., & Chiapello, L. S. (2020). Skin immunity to dermatophytes: From experimental infection models to human disease. Frontiers in Immunology, 11, 605644.

Sawada, Y., Setoyama, A., Sakuragi, Y., Saito-Sasaki, N., Yoshioka, H., & Nakamura, M. (2021). The role of IL17-producing cells in cutaneous fungal infections. International Journal of Molecular Sciences, 22(11), 5794.

Burstein, V. L., Guasconi, L., Beccacece, I., Theumer, M. G., Mena, C., Prinz, I., ... & Chiapello, L. S. (2018). il17–mediated immunity controls skin infection and t helper 1 response during experimental Microsporum canis dermatophytosis. Journal of Investigative Dermatology, 138(8), 1744-1753.

Goto, Y., Suzuki, T., Suzuki, Y., Anzawa, K., Mochizuki, T., Tamura, T., ... & Tokura, Y. (2019). Trichophyton tonsurans‐induced kerion celsi with decreased defensin expression and paradoxically increased interleukin‐17A production. The Journal of Dermatology, 46(9), 794-797.

Sakuragi, Y., Sawada, Y., Hara, Y., Ohmori, S., Omoto, D., Haruyama, S., ... & Nakamura, M. (2016). Increased circulating Th17 cell in a patient with tinea capitis caused by Microsporum canis. Allergology International, 65(2), 215-216.

Nawfal, B. N., & Zghair, F. S. (2022). Study of immune response of immune mediator interleukin (17 and 23) against dermatophytes infection. Journal of Algebraic Statistics, 13(2), 2358-2365.

Tawfek, A. R. K., Shafik, A. O., & Yousef, S. A. (2016). IL-17 Assay in Adult T-cell leukemia/lymphoma Patients with Dermatophytosis. The Egyptian Journal of Medical Microbiology (EJMM), 24(2).

Tokura, Y., Sawada, Y., & Shimauchi, T. (2014). Skin manifestations of adult T‐cell leukemia/lymphoma: clinical, cytological and immunological features. The Journal of dermatology, 41(1), 19-25.

Yoshikawa, F. S. Y., Ferreira, L. G., & de Almeida, S. R. (2015). IL-1 signaling inhibits Trichophyton rubrum conidia development and modulates the IL-17 response in vivo. Virulence, 6(5), 449-457.

Yoshikawa, F. S., Yabe, R., Iwakura, Y., De Almeida, S. R., & Saijo, S. (2016). Dectin-1 and Dectin-2 promote control of the fungal pathogen Trichophyton rubrum independently of IL-17 and adaptive immunity in experimental deep dermatophytosis. Innate immunity, 22(5), 316-324.

Spielmann, G., Bigley, A. B., & LaVoy, E. C. and Richard J. Simpson (2014). Immunology of Aging, 369.

Mázló, A., Jenei, V., Burai, S., Molnár, T., Bácsi, A., & Koncz, G. (2022). Types of necroinflammation, the effect of cell death modalities on sterile inflammation. Cell Death & Disease, 13(5), 423.

Sharma, B., & Nonzom, S. (2021). Superficial mycoses, a matter of concern: Global and Indian scenario‐an updated analysis. Mycoses, 64(8), 890-908.

Sparber, F., & LeibundGut-Landmann, S. (2018). IL-17 takes center stage in dermatophytosis. Journal of Investigative Dermatology, 138(8), 1691-1693.

Gupta, A. K., Daigle, D., & Foley, K. A. (2015). The prevalence of culture‐confirmed toenail onychomycosis in atrisk patient populations. Journal of the European Academy of Dermatology and Venereology, 29(6), 1039-1044.

Yu, P., Chen, Y., Ge, C., & Wang, H. (2021). Sexual dimorphism in placental development and its contribution to health and diseases. Critical Reviews in Toxicology, 51(6), 555-570.

Rai, G., Das, S., Ansari, M. A., Singh, P. K., Pandhi, D., Tigga, R. A., ... & Dar, S. A. (2020). The interplay among Th17 and T regulatory cells in the immune dysregulation of chronic dermatophytic infection. Microbial pathogenesis, 139, 103921.

Grover, V., Jain, A., Kapoor, A., Malhotra, R., & Singh Chahal, G. (2016). The gender bender effect in periodontal immune response. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug TargetsImmune, Endocrine & Metabolic Disorders), 16(1), 12-20.

Jaillon, S., Berthenet, K., & Garlanda, C. (2019). Sexual dimorphism in innate immunity. Clinical reviews in allergy & immunology, 56, 308-321.

Choi, J. K., Yu, C. R., Bing, S. J., Jittayasothorn, Y., Mattapallil, M. J., Kang, M., ... & Egwuagu, C. E. (2021). IL27–producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases. Proceedings of the National Academy of Sciences, 118(47), e2109548118.

Gupta, A. K., Cooper, E. A., Wang, T., Lincoln, S. A., & Bakotic, W. L. (2023). Single-Point Nail Sampling to Diagnose Onychomycosis Caused by Non-Dermatophyte Molds: Utility of Polymerase Chain Reaction (PCR) and Histopathology. Journal of Fungi, 9(6), 671.

Gnat, S., Nowakiewicz, A., Łagowski, D., & Zięba, P. (2019). Host-and pathogen-dependent susceptibility and predisposition to dermatophytosis. Journal of medical microbiology, 68(6), 823-836.

Schmid‐Wendtner, M. H., & Korting, H. C. (2007). Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell‐mediated immunity. Journal of the European Academy of Dermatology and Venereology, 21(8), 1013-1018.

Heinen, M. P., Cambier, L., Fievez, L., & Mignon, B. (2017). Are Th17 cells playing a role in immunity to dermatophytosis?. Mycopathologia, 182, 251-261.

Jartarkar, S. R., Patil, A., Goldust, Y., Cockerell, C. J., Schwartz, R. A., Grabbe, S., & Goldust, M. (2021). Pathogenesis, immunology and management of dermatophytosis. Journal of Fungi, 8(1), 39.

Omidian, Z., Ahmed, R., Giwa, A., Donner, T., & Hamad, A. R. A. (2019). IL-17 and limits of success. Cellular immunology, 339, 33-40.

Mills, K. H. (2023). IL-17 and IL-17-producing cells in protection versus pathology. Nature Reviews Immunology, 23(1), 38-54.

Hiruma, J., Harada, K., Hirayama, M., Egusa, C., Tobita, R., Masuda-Kuroki, K., ... & Okubo, Y. (2021). Blockade of the IL-17 signaling pathway increased susceptibility of psoriasis patients to superficial fungal infections. Journal of Dermatological Science, 101(2), 145-146.

Lacy, F., del Mar Melendez-Gonzalez, M., & Sayed, C. J. (2022). Dermatologic Conditions. Reichel's Care of the Elderly: Clinical Aspects of Aging, 457.

Pendlebury, G. A., Oro, P., Ludlow, K., Merideth, D., Haynes, W., Shrivastava, V., & Ludlow, K. S. (2023). Relevant Dermatoses Among US Military Service Members: An Operational Review of Management Strategies and Telemedicine Utilization. Cureus, 15(1).